Hamzany Yaniv, Crevier-Buchman Lise, Lechien Jérôme R, Bachar Gideon, Brasnu Daniel, Hans Stéphane
Department of Otolaryngology-Head and Neck Surgery, 36632Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
Ear Nose Throat J. 2021 Feb;100(1_suppl):27S-32S. doi: 10.1177/0145561320906328. Epub 2020 Feb 18.
To investigate voice quality changes of patients treated by transoral laser cordectomy (TLC) for early glottic cancer according to the type of cordectomies.
A total of 164 consecutive male patients with an early glottic cancer were prospectively recruited from the Department of Otolaryngology-Head and Neck Surgery of the Georges Pompidou European Hospital. Depending on the tumor characteristics, patients benefited from type I to VI CO cordectomy regarding the European Laryngological Society classification. The following voice quality outcomes were pre- to postoperatively assessed: voice handicap index (VHI), perceptual grade of dysphonia, roughness, breathiness, maximum phonation time, and acoustic parameters.
Fifty-five patients with Tis, T1, or T2 vocal fold cancer completed the study (mean age: 61.7 years). Of these patients, 34 and 21 composed group 1 (types I-III TLC) and group 2 (types IV-VI TLC), respectively. Voice handicap index, grade of dysphonia, and breathiness significantly improved from pre- to 3- and 6-month posttreatment in group 1. In group 2, only VHI significantly improved from pre- to 3- and 6-month posttreatment. Acoustic and aerodynamic measurements did not change throughout the postoperative course. Patients with types I to III TLC exhibited better postoperative voice outcomes compared to those treated by types IV to VI TLC.
Irrespective to the types of TLC, the subjective voice quality of patients treated by CO laser cordectomy for early glottic cancer significantly improved from pre- to 3- and 6-month posttreatment. The usefulness of aerodynamic and acoustic measurements as postoperative outcomes of voice quality changes remain controversial and require future studies considering multidimensional assessment of voice.
根据声带切除术的类型,研究经口激光声带切除术(TLC)治疗早期声门癌患者的嗓音质量变化。
从乔治·蓬皮杜欧洲医院耳鼻咽喉头颈外科前瞻性招募了164例连续的男性早期声门癌患者。根据肿瘤特征,按照欧洲喉科学会的分类,患者接受了I至VI型CO₂声带切除术。对以下嗓音质量结果进行术前和术后评估:嗓音障碍指数(VHI)、发声困难的感知分级、粗糙度、气息声、最大发声时间和声学参数。
55例Tis、T1或T2期声带癌患者完成了研究(平均年龄:61.7岁)。在这些患者中,34例和21例分别组成第1组(I至III型TLC)和第2组(IV至VI型TLC)。第1组患者的嗓音障碍指数、发声困难分级和气息声从治疗前到治疗后3个月和6个月有显著改善。在第2组中,只有VHI从治疗前到治疗后3个月和6个月有显著改善。声学和空气动力学测量在整个术后过程中没有变化。与接受IV至VI型TLC治疗的患者相比,接受I至III型TLC治疗的患者术后嗓音结果更好。
无论TLC的类型如何,CO₂激光声带切除术治疗早期声门癌患者的主观嗓音质量从治疗前到治疗后3个月和6个月有显著改善。空气动力学和声学测量作为嗓音质量变化术后结果的有用性仍存在争议,需要未来进行考虑嗓音多维度评估的研究。